Why Joints Are Hard to Heal
Cartilage has limited blood supply and poor regenerative capacity. Tendons and ligaments heal slowly because their collagen-dense structure has low metabolic activity. These properties make joint injuries among the most frustrating to treat in conventional medicine — and among the most studied applications for peptide therapy.
BPC-157 and Joint Research
The most extensive BPC-157 research on joint structures involves tendon and ligament healing in rodent models. Multiple studies have observed accelerated healing of transected tendons, with improved biomechanical properties in healed tissue. Cartilage research is less developed but includes some positive findings in animal models of osteoarthritis.
The Important Limitation
Every BPC-157 joint study has been conducted in animals. The leap from rat tendon healing to human knee cartilage regeneration involves significant uncertainty. Physicians can discuss this research honestly with patients and help calibrate realistic expectations — improvement is possible, complete regeneration of severely damaged tissue is not what the research supports.
Accessing This Protocol
Joint recovery protocols typically combine BPC-157 and TB-500, now both available through licensed 503A pharmacies following the February 2026 FDA reclassification. A physician designs the specific protocol based on your injury, imaging findings if available, and overall health status.